Equine Healthcare Market Report 2026

Equine Healthcare Market Report 2026
Global Outlook – By Product Type (Drugs, Vaccines, Medical Feed Additives ), By Disease (Equine Influenza, Equine Herpes Virus, Equine Encephalomyelitis, West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus ), By Distribution (Veterinary Hospitals And Clinics, Retail Pharmacy, Online Pharmacies) – Market Size, Trends, Strategies, and Forecast to 2035
Equine Healthcare Market Overview
• Equine Healthcare market size has reached to $1.48 billion in 2025 • Expected to grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 6.4% • Growth Driver: Zoonotic Disease Surge Is Propelling Growth In The Equine Healthcare Market • Market Trend: Introduction Of Preventative Health Care Schemes That Offer Emphasize Early Treatment • North America was the largest region in 2025.What Is Covered Under Equine Healthcare Market?
Equine healthcare refers to healthcare services that are engaged in offering services and products intended for treating horses to enhance their quality of life, to develop the quality of animal food and to increase their lifespan. Equine healthcare includes veterinary services provided to horses used for racing and betting, competitive riding, and leisure. Routine veterinary care for vaccinations, parasite control, dental care, grooming, hoof care, and protection from natural elements such as rain, wind, and snow are all part of equine healthcare. The main product types of equine healthcare are drugs, vaccines, and medical feed additives. Drugs are pharmacologically active substances administered to horses in the incident of any disease. The different diseases include equine influenza, equine herpes virus, equine encephalomyelitis, West Nile virus, equine rabies, Potomac horse fever, and tetanus and are distributed through veterinary hospitals and clinics, retail pharmacy, and online pharmacies.
What Is The Equine Healthcare Market Size and Share 2026?
The equine healthcare market size has grown strongly in recent years. It will grow from $1.48 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising equine population, increasing participation in horse racing and competitive riding, growing awareness of equine health and nutrition, advancements in veterinary drugs and vaccines, expansion of equine healthcare facilities.What Is The Equine Healthcare Market Growth Forecast?
The equine healthcare market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to adoption of precision medicine and genomics for equine care, increasing focus on performance enhancement and disease prevention, technological innovations in equine diagnostics, growth in online equine medicine distribution, rising investment in veterinary services for leisure and competitive horses. Major trends in the forecast period include increasing adoption of preventive healthcare and routine veterinary services, growing use of vaccines for core and risk-based equine diseases, rising demand for anti-inflammatories, antibiotics, and pain management drugs, expansion of nutritional supplements, probiotics, and performance enhancers, growth in veterinary hospitals, retail pharmacy, and online distribution channels.Global Equine Healthcare Market Segmentation
1) By Product Type: Drugs, Vaccines, Medical Feed Additives 2) By Disease: Equine Influenza, Equine Herpes Virus, Equine Encephalomyelitis, West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus 3) By Distribution: Veterinary Hospitals And Clinics, Retail Pharmacy, Online Pharmacies Subsegments: 1) By Drugs: Anti-Inflammatories, Antibiotics, Pain Management Medications, Anesthetics, Hormonal Therapies 2) By Vaccines: Core Vaccines, Risk-Based Vaccines, Combination Vaccines 3) By Medical Feed Additives: Nutritional Supplements, Probiotics And Prebiotics, Performance Enhancers, Medicated FeedsWhat Is The Driver Of The Equine Healthcare Market?
Rising incidences of zoonotic diseases are expected to boost the growth of the equine healthcare market going forward. Zoonotic diseases are infectious diseases caused by pathogens, such as viruses, bacteria, parasites, or fungi, that can be transmitted between animals and humans. Rising incidences of zoonotic diseases are increasing due to closer human–animal interaction, as urbanization, deforestation, and intensive farming bring people and animals into more frequent contact. The equine healthcare market supports rising incidences of zoonotic diseases, as increased disease risks drive demand for preventive care, diagnostics, and treatments to protect both animal and human health. For instance, in December 2025, according to a report published by the European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people). Therefore, rising incidences of zoonotic diseases are driving the growth of the equine healthcare industry.Key Players In The Global Equine Healthcare Market
Major companies operating in the equine healthcare market are Merck & Co. Inc., Boehringer Ingelheim, Zoetis Inc., Patterson Companies Inc., Elanco, Idexx Laboratories Inc., Covetrus, Ceva Sante Animale, Virbac, Dechra Pharmaceuticals plc, Vetoquinol, Purina Animal Nutrition LLC, Hilltop BioSciences Inc., Applied Biologics, Addison Biological Laboratory Inc., Hallmarq Veterinary Imaging, Ethos Veterinary Health LLC, Animart LLC, Prisma Imaging, Equine Therapy Solutions, Bayer Animal Health, Heska Corporation, Norbrook Laboratories, Neogen Corporation, Equine Products UK Ltd.Global Equine Healthcare Market Trends and Insights
Major companies operating in the equine healthcare market are focusing on the introduction of preventative health care schemes that offer predictable costs and emphasize early treatment. The program aims to help horse owners manage costs and encourage early diagnosis of health issues, promoting better overall equine welfare. For instance, in September 2024, Hook Norton Veterinary Group (HNVG Ltd) launched the Equiplan Gold Health Care Scheme, aimed at enhancing veterinary services for equines. This scheme emphasizes preventative health care, specifically targeting horse owners to provide predictable veterinary costs and promote early treatment of minor issues before they develop into emergencies. By encouraging proactive care, the initiative seeks to improve the overall welfare of horses while alleviating financial stress for their owners.What Are Latest Mergers And Acquisitions In The Equine Healthcare Market?
In January 2024, Altano Group, a Canada-based veterinary healthcare company, acquired McKee Pownall Equine Services for an undisclosed amount. This acquisition highlights Altano’s commitment to advancing global equine healthcare by enhancing service offerings and fostering knowledge exchange within the equine veterinary field. McKee Pownall Equine Services is a Canada-based company that specializes in performance horse care, general wellness, and emergency veterinary services.Regional Outlook
North America was the largest region in the equine healthcare market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Equine Healthcare Market?
The equine healthcare market includes revenues earned by entities by taking care of a horse for vaccinations, parasite control, and dental care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Equine Healthcare Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.58 billion |
| Revenue Forecast In 2035 | $2.02 billion |
| Growth Rate | CAGR of 6.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Disease, Distribution |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Merck & Co. Inc., Boehringer Ingelheim, Zoetis Inc., Patterson Companies Inc., Elanco, Idexx Laboratories Inc., Covetrus, Ceva Sante Animale, Virbac, Dechra Pharmaceuticals plc, Vetoquinol, Purina Animal Nutrition LLC, Hilltop BioSciences Inc., Applied Biologics, Addison Biological Laboratory Inc., Hallmarq Veterinary Imaging, Ethos Veterinary Health LLC, Animart LLC, Prisma Imaging, Equine Therapy Solutions, Bayer Animal Health, Heska Corporation, Norbrook Laboratories, Neogen Corporation, Equine Products UK Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Equine Healthcare market was valued at $1.48 billion in 2025, increased to $1.48 billion in 2026, and is projected to reach $2.02 billion by 2030.
request a sample hereThe expected CAGR for the Equine Healthcare market during the forecast period 2025–2030 is 6.4%.
request a sample hereMajor growth driver of the market includes: Rising incidences of zoonotic diseases are expected to boost the growth of the equine healthcare market going forward. Zoonotic diseases are infectious diseases caused by pathogens, such as viruses, bacteria, parasites, or fungi, that can be transmitted between animals and humans. Rising incidences of zoonotic diseases are increasing due to closer human–animal interaction, as urbanization, deforestation, and intensive farming bring people and animals into more frequent contact. The equine healthcare market supports rising incidences of zoonotic diseases, as increased disease risks drive demand for preventive care, diagnostics, and treatments to protect both animal and human health. For instance, in December 2025, according to a report published by the European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people). Therefore, rising incidences of zoonotic diseases are driving the growth of the equine healthcare market. in the Equine Healthcare market. For further insights on this market,
request a sample hereThe equine healthcare market covered in this report is segmented –
1) By Product Type: Drugs, Vaccines, Medical Feed Additives
2) By Disease: Equine Influenza, Equine Herpes Virus, Equine Encephalomyelitis, West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus
3) By Distribution: Veterinary Hospitals And Clinics, Retail Pharmacy, Online Pharmacies Subsegments:
1) By Drugs: Anti-Inflammatories, Antibiotics, Pain Management Medications, Anesthetics, Hormonal Therapies
2) By Vaccines: Core Vaccines, Risk-Based Vaccines, Combination Vaccines
3) By Medical Feed Additives: Nutritional Supplements, Probiotics And Prebiotics, Performance Enhancers, Medicated Feeds
request a sample here1) By Product Type: Drugs, Vaccines, Medical Feed Additives
2) By Disease: Equine Influenza, Equine Herpes Virus, Equine Encephalomyelitis, West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus
3) By Distribution: Veterinary Hospitals And Clinics, Retail Pharmacy, Online Pharmacies Subsegments:
1) By Drugs: Anti-Inflammatories, Antibiotics, Pain Management Medications, Anesthetics, Hormonal Therapies
2) By Vaccines: Core Vaccines, Risk-Based Vaccines, Combination Vaccines
3) By Medical Feed Additives: Nutritional Supplements, Probiotics And Prebiotics, Performance Enhancers, Medicated Feeds
Major trend in this market includes: Introduction Of Preventative Health Care Schemes That Offer Emphasize Early Treatment For further insights on this market,
request a sample hereMajor companies operating in the Equine Healthcare market are Major companies operating in the equine healthcare market are Merck & Co. Inc., Boehringer Ingelheim, Zoetis Inc., Patterson Companies Inc., Elanco, Idexx Laboratories Inc., Covetrus, Ceva Sante Animale, Virbac, Dechra Pharmaceuticals plc, Vetoquinol, Purina Animal Nutrition LLC, Hilltop BioSciences Inc., Applied Biologics, Addison Biological Laboratory Inc., Hallmarq Veterinary Imaging, Ethos Veterinary Health LLC, Animart LLC, Prisma Imaging, Equine Therapy Solutions, Bayer Animal Health, Heska Corporation, Norbrook Laboratories, Neogen Corporation, Equine Products UK Ltd.
request a sample hereNorth America was the largest region in the equine healthcare market in 2025. The regions covered in the equine healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here